XML 16 R8.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Accounting for Stock-Based Compensation
 3 Months Ended
Jun. 30, 2011
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Accounting for Stock-Based Compensation
Note 3: Accounting for Stock-Based Compensation
The Company records compensation expense associated with stock options and restricted stock in accordance with ASC Topic 718 (“Share Based Payment” ). The Company adopted the modified prospective transition method provided under ASC Topic 718. The compensation expense related to all of the Company’s stock-based compensation arrangements is recorded as a component of general and administrative expenses.

The Company had no stock options outstanding under the PetMed Express, Inc. 1998 Stock Option Plan (“1998 Plan”) as of June 30, 2011, and 13,332 options outstanding at June 30, 2010. Options generally vested ratably over a three-year period commencing on the first anniversary of the grant with respect to options granted to employees/directors under the 1998 Plan. No options have been issued since May 2005 and there was no unrecognized compensation expense related to vested stock option awards. The 1998 Plan expired on July 31, 2008. There were no stock option exercises for the quarter ended June 30, 2011. For the quarter ended June 30, 2010 the Company received $252,000 upon the exercise of stock options and the income tax benefit from stock options exercised totaled approximately $124,000 for the three months ended June 30, 2010.

The Company had 481,227 restricted common shares issued under the 2006 Employee Equity Compensation Restricted Stock Plan (“Employee Plan”) and 122,000 restricted common shares issued under the 2006 Outside Director Equity Compensation Restricted Stock Plan (“Director Plan”) at June 30, 2011, all shares of which were issued subject to a restriction or forfeiture period which will lapse ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being amortized over the three-year restriction period. The Company did not issue any shares of restricted stock during the quarter. For the quarters ended June 30, 2011 and 2010, the Company recognized $565,000 and $523,000, respectively, of compensation expense related to the Employee and Director Plans. At June 30, 2011 and 2010, there was $3.2 million and $3.9 million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the next three years.